CALCULATE YOUR SIP RETURNS

India's Outbound FDI Slows to $4.41 Billion in September 2025: RBI Data

Written by: Team Angel OneUpdated on: 9 Oct 2025, 8:12 pm IST
India’s outward FDI fell slightly to $4.41 billion in September 2025 from $4.81 billion a year earlier, though it rose significantly on a month-on-month basis.
India's Outbound FDI Slows to $4.41 Billion in September 2025: RBI Data
ShareShare on 1Share on 2Share on 3Share on 4Share on 5

India’s outward foreign direct investment (FDI) recorded a marginal decline year-on-year to $4.41 billion in September 2025, compared to $4.81 billion in the same month last year, according to data released by the Reserve Bank of India (RBI). 

Despite the slight annual dip, outbound investment showed strong momentum sequentially, rising sharply from $2.59 billion in August 2025, signalling renewed corporate activity in overseas markets.

Surge in Equity Commitments, Fall in Guarantees

Outbound FDI, which includes equity, loans, and guarantees, saw mixed trends across segments. Equity commitments surged nearly threefold to $2.57 billion in September from $828.1 million a year ago and were also higher than the $1 billion recorded in August.

Debt-related investments (loans) declined to $952.3 million from $1.21 billion in September last year, though they improved substantially from $551.2 million in August. Meanwhile, guarantees dropped sharply to $892.4 million, compared to $2.76 billion in the same month last year and $1.04 billion in August 2025.

Key Corporate Investments Abroad

Several major Indian companies made sizeable commitments to their overseas entities during the month. Prime Focus Ltd infused $348.71 million in equity into its joint venture, DNEG, based in Luxembourg. Intas Pharmaceuticals extended $213.03 million in loans to its wholly owned subsidiary, Accord Plasma B.V., in the Netherlands. 

Zydus Wellness issued guarantees worth $355.76 million for its UK-based subsidiary. Zydus Medtech committed $253.33 million in funding to its French subsidiary.

Read More: Indian Railways Records 56% Capex Utilisation by September 2025.

Conclusion

While India’s outward FDI dipped slightly year-on-year, the sharp rebound from August reflects rising investor confidence and renewed expansion by Indian corporates overseas. The surge in equity investments, led by prominent pharmaceutical and technology firms, highlights the continued internationalisation of Indian businesses despite global economic headwinds.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Published on: Oct 9, 2025, 2:42 PM IST

Team Angel One

Team Angel One is a group of experienced financial writers that deliver insightful articles on the stock market, IPO, economy, personal finance, commodities and related categories.

Know More

We're Live on WhatsApp! Join our channel for market insights & updates

Open Free Demat Account!

Join our 3 Cr+ happy customers

+91
Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy ₹0 Account Opening Charges

Get the link to download the App

Get it on Google PlayDownload on the App Store
Open Free Demat Account!
Join our 3 Cr+ happy customers